This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Manufacturer Recalls Millions of Insulin Syringes
Accusure Needles May Detach During Use
By News Staff
The company said in a press release posted on the FDA Web site that the syringes were distributed nationwide to wholesale and retail pharmacies. Affected products have the following descriptions and national drug codes:
- 28G 1/2cc, NDC 0603-6995-21;
- 28G 1cc, NDC 0603-6996-21;
- 29G 1/2cc NDC 0603-6997-21;
- 29G 1cc, NDC 0603-6998-21;
- 30G 1/2cc, NDC 0603-999-21;
- 30G 1cc, NDC 0603-7000-21;
- 31G 1/2cc, NDC 0603-7001-21; and
- 31G 1cc, NDC 0603-7002-21.
Consumers who have Accusure insulin syringes should stop using them and contact Qualitest at (800) 444-4011 for reimbursement. The company said it is notifying customers who received the syringes and is arranging for the return of affected products.
As always, adverse reactions or quality problems may be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
FDA: Recalls, Market Withdrawals & Safety Alerts
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Birth Defects Linked to Fluconazole Prompt FDA Warning
FDA Warns of Mixing Certain MAOIs, Serotonergic Drugs
Oseltamivir Concentration Revised to Ensure Accurate Dosing
Teledermatology Project Aids Underserved Patients
